Mirati Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
171.00
199.00
212.00
180.00
184.00
-
Gross Income
171.00
199.00
212.00
180.00
184.00
-
SG&A Expense
31,601.00
38,571.00
64,502.00
83,599.00
71,351.00
115,378
EBIT
31,772.00
38,770.00
64,714.00
83,779.00
71,535.00
102,627
Unusual Expense
20,824.00
4,851.00
-
-
-
-
Non Operating Income/Expense
1,320.00
200.00
100.00
-
-
-
Pretax Income
53,713.00
43,698.00
64,544.00
83,118.00
70,430.00
98,418
Income Tax
854.00
-
-
-
-
-
Consolidated Net Income
52,859.00
43,698.00
64,544.00
83,118.00
70,430.00
98,418
Net Income
52,859.00
43,698.00
64,544.00
83,118.00
70,430.00
98,418
Net Income After Extraordinaries
52,859.00
43,698.00
64,544.00
83,118.00
70,430.00
98,418
Net Income Available to Common
52,859.00
43,698.00
64,544.00
83,118.00
70,430.00
98,418
EPS (Basic)
4.78
3.24
3.82
4.20
2.78
3.19
Basic Shares Outstanding
11,057.00
13,483.50
16,901.80
19,787.30
25,290.20
30,897.70
EPS (Diluted)
4.78
3.24
3.82
4.20
2.78
3.19
Diluted Shares Outstanding
11,057.00
13,483.50
16,901.80
19,787.30
25,290.20
30,897.70
EBITDA
31,601.00
38,571.00
64,502.00
83,599.00
71,351.00
102,452
Non-Operating Interest Income
203.00
123.00
270.00
661.00
1,105.00
4,209
About Mirati Therapeutics
View Profile
